<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47360/1995-4484-2025-279-285</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-3765</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Бессимптомная гиперурикемия и подагра: различия метаболических нарушений и спектра сопутствующих заболеваний (данные пилотного исследования «случай-контроль»)</article-title><trans-title-group xml:lang="en"><trans-title>Asymptomatic hyperuricemia and gout: Are there any differences (data from a pilot case-control study)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1191-5831</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Елисеев</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Eliseev</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34а</p></bio><bio xml:lang="en"><p>Maxim S. Eliseev.</p><p>115522, Moscow, Kashirskoye Highway, 34A</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4383-9872</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Панина</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Panina</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Панина Елена Владимировна.</p><p>115522, Москва, Каширское шоссе, 34а</p></bio><bio xml:lang="en"><p>Elena V. Panina.</p><p>115522, Moscow, Kashirskoye Highway, 34A</p></bio><email xlink:type="simple">buipvybho@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5394-7869</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Желябина</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zheliabina</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34а</p></bio><bio xml:lang="en"><p>Olga V. Zheliabina.</p><p>115522, Moscow, Kashirskoye Highway, 34A</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>02</day><month>07</month><year>2025</year></pub-date><volume>63</volume><issue>3</issue><fpage>279</fpage><lpage>285</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Елисеев М.С., Панина Е.В., Желябина О.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Елисеев М.С., Панина Е.В., Желябина О.В.</copyright-holder><copyright-holder xml:lang="en">Eliseev M.S., Panina E.V., Zheliabina O.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/3765">https://rsp.mediar-press.net/rsp/article/view/3765</self-uri><abstract><p>Бессимптомная гиперурикемия (БГУ) и подагра характеризуются наличием повышенного уровня мочевой кислоты (МК). Есть ли различия между данными состояниями, помимо острых приступов артрита, характерных только для подагры, не известно.</p><p>Цель исследования – выявление различий в частоте сопутствующих заболеваний, обменных нарушений и пищевых привычках у пациентов с подагрой и бессимптомной гиперурикемией.</p><sec><title>Материал и методы</title><p>Материал и методы. В одномоментное обсервационное исследование «случай-контроль» включено 202 человека: по 101 пациенту с БГУ и подагрой, сопоставимых по возрасту и полу. Обследование включало сбор анамнеза и данных медицинской документации о наличии сердечно-сосудистых заболеваний, сахарного диабета 2-го типа (СД2), нефролитиаза; осмотр и измерение антропометрических данных. Фиксировался прием лекарственных препаратов. Проведено анкетирование для оценки частоты потребления мяса, морепродуктов и алкоголя. В крови определяли уровни глюкозы, МК, аланинаминотрансферазы (АЛТ), аспартатаминотрансферазы (АСТ), гамма-глутамилтрансферазы (ГГТ), щелочной фосфатазы (ЩФ), креатинина, холестерина, С-реактивного белка (СРБ), скорости оседания эритроцитов по Вестергрену. Расчет скорости клубочковой фильтрации (СКФ) проведен по формуле CKD-EPI. Всем пациентам проведено ультразвуковое исследование (УЗИ) коленных суставов для определения признаков синовита и депонирования кристаллов моноурата натрия (МУН).</p></sec><sec><title>Результат</title><p>Результат. У пациентов с подагрой чаще, чем при БГУ, выявлялись артериальная гипертензия (АГ) – у 86 (85,1%) и 53 (52,4%) пациентов соответственно (р&lt;0,05) и СД2 – у 12 (11,9%) и 4 (4,0%) пациентов соответственно (р&lt;0,05). В группе подагры было больше пациентов, принимающих алкоголь ≥1 раза в неделю (р=0,02), тогда как частота потребления мяса и морепродуктов существенно не различалась. Среди больных подагрой было больше пациентов с СКФ&lt;60 мл/мин/1,73 м2. В группе подагры отмечалась статистически значимая прямая корреляция уровня МК с концентрацией АЛТ, креатинина, СРБ и обратная – между содержанием МК сыворотки и СКФ. При подагре УЗИ коленных суставов показало статистически значимо более частое, чем при БГУ, депонирование кристаллов МУН (у 46 (45,5%) и 17 (16,8%) пациентов соответственно; р&lt;0,05) и наличие синовита (у 37 (36,6%) и 14 (13,8%) пациентов соответственно; р&lt;0,05).</p></sec><sec><title>Выводы</title><p>Выводы. Несмотря на кажущуюся общность подагры и БГУ, они имеют ряд различий. При подагре чаще выявляются АГ и СД2. Также у пациентов с подагрой отмечается статистически значимая прямая корреляция уровня МК с концентрацией АЛТ, креатинина и СРБ, в то время как СКФ обратно коррелировала с уровнем сывороточной МК. Среди пациентов с БГУ подобные корреляционные связи не обнаружены. Также при подагре статистически значимо более часто выявлялось депонирование кристаллов МУН. Употребление мясной и рыбной продукции не различалось в обеих группах.</p></sec></abstract><trans-abstract xml:lang="en"><p>Asymptomatic hyperuricemia (AH) and gout are characterized by the presence of elevated uric acid (UA) levels. It is not known whether there are differences between these conditions, beyond the acute attacks of arthritis unique to gout.</p><p>The aim – to identify differences in the frequency of concomitant diseases, metabolic disorders and dietary habits in patients with gout and asymptomatic hyperuricemia.</p><sec><title>Material and methods</title><p>Material and methods. A single-stage observational case-control study included 202 people: 101 patients each with AH and gout, matched by age and gender. The examination included collection of anamnesis and medical documentation data on the presence of cardiovascular diseases, type 2 diabetes mellitus (T2DM), nephrolithiasis; inspection and measurement of anthropometric data. The intake of medications was recorded. A survey was conducted regarding the frequency of consumption of meat, seafood and alcohol. Blood levels of glucose, sUA, alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyltransferase (GGT), alkaline phosphatase (ALP), creatinine, cholesterol, C-reactive protein (CRP), and ESR according to Westergren were determined. GFR was calculated using the CKD-EPI formula. All patients underwent ultrasound examination of the knee joints to determine signs of synovitis and deposition of monosodium urate (MSU) crystals.</p></sec><sec><title>Result</title><p>Result. In patients with gout, arterial hypertension (86 (85.1%) vs 53 (52.4%) patients, respectively; p&lt;0.05), T2DM (12 (11.9%) vs 4 (4.0%) patients, respectively; p&lt;0.05) were detected more often than in patients with AH. In the gout group, there were more patients consuming alcohol ≥1 time per week (p=0.02), while there were no differences in the frequency of consumption of meat and seafood. Among patients with gout, there were more participants with GFR&lt;60 ml/min/1.73 m2. In patients with gout, there was a significant direct correlation between the levels of UA and ALT, creatinine, CRP, and an inverse correlation between serum UA and GFR. Ultrasound of the knee joints showed a significantly more frequent deposition of MSU crystals (46 (45.5%) vs 17 (16.8%) patients, respectively; p&lt;0.05) and the presence of synovitis (37 (36.6%) vs 14 (13.8%) patients, respectively; p&lt;0.05) in the gout group.</p></sec><sec><title>Conclusions</title><p>Conclusions. Despite the apparent commonality of gout and AH, they have a number of differences. In gout, arterial hypertension and T2DM are more often detected. Also, in patients with gout, there is a significant direct correlation between the levels of sUA and ALT, creatinine, CRP, while GFR is inversely correlated with the level of serum sUA. Among patients with AH, such correlations were not found. Gout also predicts a statistically more frequent detection of MSU crystal deposits (45.5% vs 31.1% of patients). The intake of meat and fish products did not differ in both groups.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>гиперурикемия</kwd><kwd>подагра</kwd><kwd>артрит</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hyperuricemia</kwd><kwd>gout</kwd><kwd>arthritis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Статья подготовлена в рамках фундаментального научного исследования по теме «Разработка подходов к фенотипированию аутовоспалительных ревматических заболеваний на основе сравнительного изучения биохимических, иммунологических и генетических факторов, связанных с состоянием костной, хрящевой, мышечной и жировой ткани» (№ 125020501433-4).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Dalbeth N, Phipps-Green A, Frampton C, Neogi T, Taylor WJ, Merriman TR. Relationship between serum urate concentration and clinically evident incident gout: An individual participant data analysis. Ann Rheum Dis. 2018;77(7):1048-1052. doi: 10.1136/annrheumdis-2017-212288</mixed-citation><mixed-citation xml:lang="en">Dalbeth N, Phipps-Green A, Frampton C, Neogi T, Taylor WJ, Merriman TR. Relationship between serum urate concentration and clinically evident incident gout: An individual participant data analysis. Ann Rheum Dis. 2018;77(7):1048-1052. doi: 10.1136/annrheumdis-2017-212288</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Perez-Ruiz F, Dalbeth N, Bardin T. A review of uric acid, crystal deposition disease, and gout. Adv Ther. 2015;32(1):31-41. doi: 10.1007/s12325-014-0175-z</mixed-citation><mixed-citation xml:lang="en">Perez-Ruiz F, Dalbeth N, Bardin T. A review of uric acid, crystal deposition disease, and gout. Adv Ther. 2015;32(1):31-41. doi: 10.1007/s12325-014-0175-z</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Liu S, Liu Y, Wu X, Liu Z. Metabolomic analysis for asymptomatic hyperuricemia and gout based on a combination of dried blood spot sampling and mass spectrometry technology. J Orthop Surg Res. 2023;18(1):769. doi: 10.1186/s13018-023-04240-3</mixed-citation><mixed-citation xml:lang="en">Liu S, Liu Y, Wu X, Liu Z. Metabolomic analysis for asymptomatic hyperuricemia and gout based on a combination of dried blood spot sampling and mass spectrometry technology. J Orthop Surg Res. 2023;18(1):769. doi: 10.1186/s13018-023-04240-3</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Шальнова СА, Деев АД, Артамонова ГВ, Дупляков ДВ, Ефанов АЮ, Жернакова ЮВ, и др. Гиперурикемия и ее корреляты в российской популяции (результаты эпидемиологического исследования ЭССЕ-РФ). Рациональная фармакотерапия в кардиологии. 2014;10(2):153-159. doi: 10.20996/1819-6446-2014-10-2-153-159</mixed-citation><mixed-citation xml:lang="en">Shalnova SA, Deev AD, Artamonov GV, Duplyakov DV, Efanov AYu, Zhernakova YuV, et al. Hyperuricemia and its correlates in the Russian population (results of ESSE-RF epidemiological study). Rational Pharmacotherapy in Cardiology. 2014;10(2):153-159 (In Russ.). doi: 10.20996/1819-6446-2014-10-2-153-159</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Елисеев МС, Барскова ВГ. Метаболический синдром при подагре. Вестник Российской академии медицинских наук. 2008;6:29-32.</mixed-citation><mixed-citation xml:lang="en">Eliseev MS, Barskova VG. Metabolic syndrome in gout. Bulletin of the Russian Academy of Medical Sciences. 2008;6:26-32 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Del Pinto R, Viazzi F, Pontremoli R, Ferri C, Carubbi F, Russo E. The URRAH study. Panminerva Med. 2021;63(4):416-423. doi: 10.23736/S0031-0808.21.04357-3</mixed-citation><mixed-citation xml:lang="en">Del Pinto R, Viazzi F, Pontremoli R, Ferri C, Carubbi F, Russo E. The URRAH study. Panminerva Med. 2021;63(4):416-423. doi: 10.23736/S0031-0808.21.04357-3</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kuo CF, See LC, Luo SF, Ko YS, Lin YS, Hwang JS, et al. Gout: An independent risk factor for all-cause and cardiovascular mortality. Rheumatology (Oxford). 2010;49(1):141-146. doi: 10.1093/rheumatology/kep364</mixed-citation><mixed-citation xml:lang="en">Kuo CF, See LC, Luo SF, Ko YS, Lin YS, Hwang JS, et al. Gout: An independent risk factor for all-cause and cardiovascular mortality. Rheumatology (Oxford). 2010;49(1):141-146. doi: 10.1093/rheumatology/kep364</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Liang J, Jiang Y, Huang Y, Song W, Li X, Huang Y, et al. The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: A cross-sectional study. Lipids Health Dis. 2020;19(1):31. doi: 10.1186/s12944-020-1197-y</mixed-citation><mixed-citation xml:lang="en">Liang J, Jiang Y, Huang Y, Song W, Li X, Huang Y, et al. The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: A cross-sectional study. Lipids Health Dis. 2020;19(1):31. doi: 10.1186/s12944-020-1197-y</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Liu S, Sun H, Yang S, Liang N, Gao Y, Qu S, et al. Clustering of gout-related comorbidities and their relationship with gout flares: A data-driven cluster analysis of eight comorbidities. J Endocrinol Invest. 2024;47(5):1119-1128. doi: 10.1007/s40618-023-02224-y</mixed-citation><mixed-citation xml:lang="en">Liu S, Sun H, Yang S, Liang N, Gao Y, Qu S, et al. Clustering of gout-related comorbidities and their relationship with gout flares: A data-driven cluster analysis of eight comorbidities. J Endocrinol Invest. 2024;47(5):1119-1128. doi: 10.1007/s40618-023-02224-y</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bursill D, Taylor WJ, Terkeltaub R, Abhishek A, So AK, Vargas-Santos AB, et al. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout. Ann Rheum Dis. 2019;78(11):1592-1600. doi: 10.1136/annrheumdis-2019-215933</mixed-citation><mixed-citation xml:lang="en">Bursill D, Taylor WJ, Terkeltaub R, Abhishek A, So AK, Vargas-Santos AB, et al. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout. Ann Rheum Dis. 2019;78(11):1592-1600. doi: 10.1136/annrheumdis-2019-215933</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Liu W, Song H, Man S, Li H, Gao S. Simple metabolic markers associated with tophaceous gout. Clin Rheumatol. 2021;40(12):5047-5053. doi: 10.1007/s10067-021-05861-x</mixed-citation><mixed-citation xml:lang="en">Liu W, Song H, Man S, Li H, Gao S. Simple metabolic markers associated with tophaceous gout. Clin Rheumatol. 2021;40(12):5047-5053. doi: 10.1007/s10067-021-05861-x</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Nian YL, You CG. Susceptibility genes of hyperuricemia and gout. Hereditas. 2022;159(1):30. doi: 10.1186/s41065-022-00243-y</mixed-citation><mixed-citation xml:lang="en">Nian YL, You CG. Susceptibility genes of hyperuricemia and gout. Hereditas. 2022;159(1):30. doi: 10.1186/s41065-022-00243-y</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Choi HK, Mount DB, Reginato AM; American College of Physicians; American Physiological Society. Pathogenesis of gout. Ann Intern Med. 2005;143(7):499-516. doi: 10.7326/0003-4819-143-7-200510040-00009</mixed-citation><mixed-citation xml:lang="en">Choi HK, Mount DB, Reginato AM; American College of Physicians; American Physiological Society. Pathogenesis of gout. Ann Intern Med. 2005;143(7):499-516. doi: 10.7326/0003-4819-143-7-200510040-00009</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Merriman TR. An update on the genetic architecture of hyperuricemia and gout. Arthritis Res Ther. 2015;17(1):98. doi: 10.1186/s13075-015-0609-2</mixed-citation><mixed-citation xml:lang="en">Merriman TR. An update on the genetic architecture of hyperuricemia and gout. Arthritis Res Ther. 2015;17(1):98. doi: 10.1186/s13075-015-0609-2</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yang Q, Köttgen A, Dehghan A, Smith AV, Glazer NL, Chen MH, et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet. 2010;3(6):523-530. doi: 10.1161/CIRCGENETICS.109.934455</mixed-citation><mixed-citation xml:lang="en">Yang Q, Köttgen A, Dehghan A, Smith AV, Glazer NL, Chen MH, et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet. 2010;3(6):523-530. doi: 10.1161/CIRCGENETICS.109.934455</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Pei L, Xie L, Wu J, Zhang H, Zhang X. Study on the relationship between FFA and gout flare. Clin Rheumatol. 2020;39(4):1251-1255. doi: 10.1007/s10067-019-04903-9</mixed-citation><mixed-citation xml:lang="en">Pei L, Xie L, Wu J, Zhang H, Zhang X. Study on the relationship between FFA and gout flare. Clin Rheumatol. 2020;39(4):1251-1255. doi: 10.1007/s10067-019-04903-9</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kuo CF, Luo SF. Gout: Risk of premature death in gout unchanged for years. Nat Rev Rheumatol. 2017;13(4):200-201. doi: 10.1038/nrrheum.2017.27</mixed-citation><mixed-citation xml:lang="en">Kuo CF, Luo SF. Gout: Risk of premature death in gout unchanged for years. Nat Rev Rheumatol. 2017;13(4):200-201. doi: 10.1038/nrrheum.2017.27</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Maloberti A, Mengozzi A, Russo E, Cicero AFG, Angeli F, Agabiti Rosei E, et al.; Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA). The results of the URRAH (Uric Acid Right for Heart Health) project: A focus on hyperuricemia in relation to cardiovascular and kidney disease and its role in metabolic dysregulation. High Blood Press Cardiovasc Prev. 2023;30(5):411-425. doi: 10.1007/s40292-023-00602-4</mixed-citation><mixed-citation xml:lang="en">Maloberti A, Mengozzi A, Russo E, Cicero AFG, Angeli F, Agabiti Rosei E, et al.; Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA). The results of the URRAH (Uric Acid Right for Heart Health) project: A focus on hyperuricemia in relation to cardiovascular and kidney disease and its role in metabolic dysregulation. High Blood Press Cardiovasc Prev. 2023;30(5):411-425. doi: 10.1007/s40292-023-00602-4</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ghasemi A. Uric acid-induced pancreatic β-cell dysfunction. BMC Endocr Disord. 2021;21(1):24. doi: 10.1186/s12902-021-00698-6</mixed-citation><mixed-citation xml:lang="en">Ghasemi A. Uric acid-induced pancreatic β-cell dysfunction. BMC Endocr Disord. 2021;21(1):24. doi: 10.1186/s12902-021-00698-6</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Желябина ОВ, Елисеев МС, Глухова СИ, Насонов ЕЛ. Факторы, влияющие на развитие сахарного диабета 2-го типа у пациентов с подагрой (результаты многолетнего проспективного исследования). Научно-практическая ревматология. 2022;60(3):374-380. doi: 10.47360/1995-4484-2022-374-380</mixed-citation><mixed-citation xml:lang="en">Zheliabina OV, Eliseev MS, Glukhova SI, Nasonov EL. Contributing factors of diabetes mellitus among patients with gout (results of the long-term prospective study). Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2022;60(3):374-380 (In Russ.). doi: 10.47360/1995-4484-2022-374-380</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Cicero AFG, Fogacci F, Giovannini M, Grandi E, Rosticci M, D’Addato S, et al. Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study. Sci Rep. 2018;8(1):11529. doi: 10.1038/s41598-018-29955-w</mixed-citation><mixed-citation xml:lang="en">Cicero AFG, Fogacci F, Giovannini M, Grandi E, Rosticci M, D’Addato S, et al. Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study. Sci Rep. 2018;8(1):11529. doi: 10.1038/s41598-018-29955-w</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Hernández-Cuevas CB, Roque LH, Huerta-Sil G, Rojas-Serrano J, Escudero A, Perez LL, et al. First acute gout attacks commonly precede features of the metabolic syndrome. J Clin Rheumatol. 2009;15(2):65-67. doi: 10.1097/RHU.0b013e31819c0dba</mixed-citation><mixed-citation xml:lang="en">Hernández-Cuevas CB, Roque LH, Huerta-Sil G, Rojas-Serrano J, Escudero A, Perez LL, et al. First acute gout attacks commonly precede features of the metabolic syndrome. J Clin Rheumatol. 2009;15(2):65-67. doi: 10.1097/RHU.0b013e31819c0dba</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Comorbidities in patients with gout prior to and following diagnosis: Case-control study. Ann Rheum Dis. 2016;75(1):210-217. doi: 10.1136/annrheumdis-2014-206410</mixed-citation><mixed-citation xml:lang="en">Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Comorbidities in patients with gout prior to and following diagnosis: Case-control study. Ann Rheum Dis. 2016;75(1):210-217. doi: 10.1136/annrheumdis-2014-206410</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Черемушкина ЕВ, Елисеев МС. Гиперурикемия и подагра: влияние на костный метаболизм и суставной хрящ (обзор литературы). Ожирение и метаболизм. 2022;19(3):348-357. doi: 10.14341/omet12894</mixed-citation><mixed-citation xml:lang="en">Cheremushkina EV, Eliseev MS. Hyperuricemia and gout: Effects on bone and articular cartilage (literature review). Obesity and Metabolism. 2022;19(3):348-357 (In Russ.). doi: 10.14341/omet12894</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Sah SK, Khatiwada S, Pandey S, Kc R, Das BK, Baral N, et al. Association of high-sensitivity C-reactive protein and uric acid with the metabolic syndrome components. Springerplus. 2016;5:269. doi: 10.1186/s40064-016-1933-y</mixed-citation><mixed-citation xml:lang="en">Sah SK, Khatiwada S, Pandey S, Kc R, Das BK, Baral N, et al. Association of high-sensitivity C-reactive protein and uric acid with the metabolic syndrome components. Springerplus. 2016;5:269. doi: 10.1186/s40064-016-1933-y</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Lawler PR, Bhatt DL, Godoy LC, Lüscher TF, Bonow RO, Verma S, et al. Targeting cardiovascular inflammation: Next steps in clinical translation. Eur Heart J. 2021;42(1):113-131. doi: 10.1093/eurheartj/ehaa099</mixed-citation><mixed-citation xml:lang="en">Lawler PR, Bhatt DL, Godoy LC, Lüscher TF, Bonow RO, Verma S, et al. Targeting cardiovascular inflammation: Next steps in clinical translation. Eur Heart J. 2021;42(1):113-131. doi: 10.1093/eurheartj/ehaa099</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Rodnan GP. The pathogenesis of aldermanic gout: Procatarctic role of fluctuations in serum urate concentration in gouty arthritis provoked by feast and alcohol. Arthritis Rheum. 1980;23(Suppl):737.</mixed-citation><mixed-citation xml:lang="en">Rodnan GP. The pathogenesis of aldermanic gout: Procatarctic role of fluctuations in serum urate concentration in gouty arthritis provoked by feast and alcohol. Arthritis Rheum. 1980;23(Suppl):737.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: A prospective study. Lancet. 2004;363(9417):1277-1281. doi: 10.1016/S0140-6736(04)16000-5</mixed-citation><mixed-citation xml:lang="en">Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: A prospective study. Lancet. 2004;363(9417):1277-1281. doi: 10.1016/S0140-6736(04)16000-5</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
